Vortex Biosciences

About

Vortex Biosciences is an oncology diagnostics company that integrates cancer biology, microfluidic engineering.

Menlo Park,California,United States
11 - 50

Highlights

Details

Last Funding Type: Corporate Round
Last Funding Money Raised: £300K
Industries: Biotechnology,Health Care,Medical
Founded date: Jan 1, 2012
Number Of Employee: 11 - 50
Operating Status: Active

Vortex Biosciences is an oncology diagnostics company that integrates cancer biology, microfluidic engineering and informatics to deliver better tools for isolating and characterizing circulating tumor cells (CTCs). Vortex’s first product, the VTX-1 Liquid Biopsy System, automates the label free isolation and collection of viable CTCs directly from whole blood.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

3

£2.30M

Vortex Biosciences has raised a total of £2.30M in funding over 2 rounds. Their latest funding was raised on Aug 16, 2022 from a Debt Financing round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Aug 16, 2022	Debt Financing	£2M	1	NetScientific PLC	—	Detail
May 6, 2022	Corporate Round	£300K	1	NetScientific PLC	—	Detail
Mar 22, 2019	Series A	—	1	EMV Capital	—	Detail